Palisade Asset Management’s CME Group CME Stock Holding History

Palisade Asset Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$271	–	284
2025 Q3	$271	Buy	+1	New	+$272	﹤0.01%	627
2024 Q2	–	Sell	-32	Closed	-$6.89K	–	234
2024 Q1	$6.89K	Buy	+32	New	+$6.72K	﹤0.01%	361

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Palisade Asset Management's CME Position: Q4 2025 in Review

Palisade Asset Management sold out of CME Group (CME) in Q4 2025, closing a stake of 1 share — an estimated $271 sold.

Palisade Asset Management first reported a position in CME in Q1 2024 and held it in 2 quarters. The position peaked at $6.89K in Q1 2024. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.

Palisade Asset Management reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
Palisade Asset Management sold 1 CME Group share in Q4 2025, an estimated $271.
Palisade Asset Management first reported a position in CME Group in Q1 2024 and held it in 2 quarters.
Palisade Asset Management's CME Group position peaked at $6.89K in Q1 2024.
1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Palisade Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.